The oxindole/imidazole derivative C16 reduces in vivo brain PKR activation
Authors:
- 21 August 2007
- journal article
- Published by Wiley in FEBS Letters
- Vol. 581 (23) , 4473-4478
Abstract
Inhibition of double‐stranded RNA‐dependent protein kinase (PKR) represents an interesting strategy for neuroprotection. However, inhibiting this kinase which triggers the apoptotic process could favour in counterpart cell proliferation and tumorigenesis. Here, we use an in vivo model of 7‐day‐old rat displaying a high activation of brain PKR to investigate the effects of a new PKR inhibitor identified as an oxindole/imidazole derivative (C16). We show for the first time that acute systemic injection of C16 specifically inhibits the apoptotic PKR/eIF2α signaling pathway without stimulating the proliferative mTOR/p70S6K signaling mechanism.Keywords
This publication has 25 references indexed in Scilit:
- Inhibitor of double stranded RNA-dependent protein kinase protects against cell damage induced by ER stressNeuroscience Letters, 2006
- The mTOR Pathway in the Control of Protein SynthesisPhysiology, 2006
- The immunosuppressant rapamycin exacerbates neurotoxicity of Aβ peptideJournal of Neuroscience Research, 2006
- mTOR/p70S6k signalling alteration by Aβ exposure as well as in APP‐PS1 transgenic models and in patients with Alzheimer's diseaseJournal of Neurochemistry, 2005
- Development of the blood-brain barrierCell and tissue research, 2003
- Phosphorylation of eukaryotic initiation factor-2α (eIF2α) is associated with neuronal degeneration in Alzheimerʼs diseaseNeuroReport, 2002
- Involvement of double‐stranded RNA‐dependent protein kinase and phosphorylation of eukaryotic initiation factor‐2α in neuronal degenerationJournal of Neurochemistry, 2002
- PKR; a sentinel kinase for cellular stressOncogene, 1999
- Ribosomal S6 Kinase Signaling and the Control of TranslationExperimental Cell Research, 1999
- Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinaseScience, 1992